Dedifferentiated thyroid cancer: a therapeutic challenge

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Alessandro AntonelliPaolo Miccoli

Abstract

Human papillary dedifferentiated thyroid cancer (HPDTC) represents a therapeutic dilemma. Targeted therapy (RET proto-oncogene or BRAF-targeting drugs) are promising treatments for HPDTC. Also PPARg agonists are another exciting field for redifferentiating therapy of HPDTC. However, even if many new approaches for the therapy of HPDTC are emerging, until now a significant clinical impact on survival by the use of these drugs is still lacking. In the future, the identification of patients who are likely to benefit from each therapeutic option will be important. In this view particular importance should be given to development of primary cells from the single patient by fine needle aspiration samples, as recently observed in anaplastic thyroid cancer. In fact, chemosensitivity tests in primary tumoral cells may help in detecting responsive patients and in preventing the administration of inactive drugs to those unresponsive.

References

Apr 29, 1998·The Journal of Clinical Investigation·T SaitoT Onaya
Jan 16, 1999·Seminars in Surgical Oncology·B R Haugen
Jul 15, 1999·The Journal of Clinical Endocrinology and Metabolism·G M VenkataramanK B Ain
Nov 27, 1999·European Journal of Endocrinology·S FilettiM Schlumberger
Mar 27, 2003·European Journal of Endocrinology·Thomas GrüningWolf-Gunter Franke
May 3, 2003·The Journal of Clinical Endocrinology and Metabolism·Milena Braga-Basaria, Matthew D Ringel
Dec 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Maria G CatalanoGiuseppe Boccuzzi
Jan 6, 2005·Clinical Oncology : a Journal of the Royal College of Radiologists·S C ShortC Harmer
Feb 3, 2005·The Journal of Clinical Endocrinology and Metabolism·Valérie PorraBernard Rousset
Jul 15, 2005·The New England Journal of Medicine·Daniela S Krause, Richard A Van Etten
Mar 2, 2006·Journal of the National Cancer Institute·Francesca CarlomagnoMassimo Santoro
Mar 23, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bin OuyangJames A Fagin
Jun 3, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maher N YounesJeffrey N Myers
Jun 15, 2006·The Journal of Clinical Endocrinology and Metabolism·Zhaowen ZhuYuri E Nikiforov
Aug 26, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Massimo Santoro, Francesca Carlomagno
Sep 2, 2006·Endocrinology·Motoo ShinoharaMatthew D Ringel
Sep 2, 2006·Endocrinology·Mingzhao Xing
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Quang T LuongH Phillip Koeffler

❮ Previous
Next ❯

Citations

Jan 31, 2012·Current Oncology Reports·Alessandro AntonelliClodoveo Ferri
Mar 19, 2011·Updates in Surgery·Antonio ToniatoMaria Rosa Pelizzo
Jul 3, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Poupak FallahiAlessandro Antonelli
Mar 16, 2013·Thyroid : Official Journal of the American Thyroid Association·Kevin B KimSteven I Sherman
Jul 16, 2010·Journal of Oncology·Alessandro AntonelliPoupak Fallahi
Jan 18, 2013·Journal of Thyroid Research·Arash SafaviMarlon A Guerrero
Apr 25, 2012·Journal of Thyroid Research·Naifa Lamki Busaidy, Maria E Cabanillas
Nov 16, 2013·Annals of Nuclear Medicine·Zekiye HasbekTaner Erselcan
Mar 20, 2015·International Journal of Molecular Sciences·Poupak FallahiAlessandro Antonelli
Jul 15, 2015·Expert Review of Anticancer Therapy·Silvia Martina FerrariPoupak Fallahi
Jun 5, 2014·Expert Opinion on Drug Delivery·Roberto VitaSalvatore Benvenga
Nov 6, 2013·Autoimmunity Reviews·Alessandro AntonelliPoupak Fallahi
Sep 25, 2012·The Journal of Surgical Research·David A KleimanRasa Zarnegar
Sep 20, 2011·Molecular and Cellular Endocrinology·Mohsen MalehmirSeyed H Ghaffari
Dec 5, 2015·Frontiers in Endocrinology·Silvia Martina FerrariAlessandro Antonelli
Nov 10, 2014·Immunologic Research·Alessandro AntonelliPoupak Fallahi
Sep 1, 2015·Advances in Medical Sciences·Silvia Martina FerrariPoupak Fallahi
Nov 7, 2014·International Journal of Endocrinology·Poupak FallahiAlessandro Antonelli
May 14, 2014·Expert Opinion on Drug Safety·Poupak FallahiAlessandro Antonelli
Feb 28, 2015·PPAR Research·Silvia Martina FerrariSalvatore Benvenga
Dec 3, 2014·Autoimmunity Reviews·Alessandro AntonelliPoupak Fallahi
Feb 10, 2012·Yonsei Medical Journal·Sun Min LimByoung Chul Cho
Aug 20, 2018·Endocrine-related Cancer·Veronica VellaAntonino Belfiore
Oct 19, 2016·The Journal of Clinical Endocrinology and Metabolism·Weibin WangThomas J Fahey
Apr 16, 2010·The Journal of Clinical Endocrinology and Metabolism·Maria E CabanillasNaifa L Busaidy
Sep 19, 2009·Expert Review of Anticancer Therapy·Paolo MiccoliMichele N Minuto
Mar 1, 2012·Expert Review of Anticancer Therapy·Katarina L KojicSam M Wiseman
Jan 27, 2012·The Journal of Clinical Endocrinology and Metabolism·Alessandro AntonelliPaolo Miccoli
Sep 20, 2012·European Journal of Endocrinology·Luca GiovanellaLuca Ceriani
Oct 18, 2016·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Ana Kober Nogueira LeiteLeandro Luongo Matos
Mar 23, 2011·Expert Review of Anticancer Therapy·Stefan L KojicSam M Wiseman
Jul 31, 2018·Expert Review of Endocrinology & Metabolism·Poupak FallahiSilvia Martina Ferrari
Nov 10, 2020·Cell Death and Differentiation·Yina LiaoWuguo Deng
May 4, 2021·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Hao FuLibo Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis